These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 10585796

  • 1. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
    Ribera E, Fernandez-Sola A, Juste C, Rovira A, Romero FJ, Armadans-Gil L, Ruiz I, Ocaña I, Pahissa A.
    Clin Infect Dis; 1999 Dec; 29(6):1461-6. PubMed ID: 10585796
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for toxoplasmic encephalitis in HIV-infected patients: a case-control study in Brazil.
    Nascimento LV, Stollar F, Tavares LB, Cavasini CE, Maia IL, Cordeiro JA, Ferreira MU.
    Ann Trop Med Parasitol; 2001 Sep; 95(6):587-93. PubMed ID: 11672464
    [Abstract] [Full Text] [Related]

  • 3. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C, Pezzotti P, Govoni A, Borghi V, Antinori A, d'Arminio Monforte A, De Luca A, Mongiardo N, Cerri MC, Chiodo F, Concia E, Bonazzi L, Moroni M, Ortona L, Esposito R, Cossarizza A, De Rienzo B.
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [Abstract] [Full Text] [Related]

  • 4. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
    Koch A, Kothe H, Braun J, Kämmerer R, Friedrich HJ, Dalhoff K.
    Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D, Bergmann F, Albrecht H, Padberg J, Wünsche T, Grünewald T, Schürmann M, Grobusch M, Vallée M, Ruf B, Suttorp N.
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [Abstract] [Full Text] [Related]

  • 6. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
    Schürmann D, Bergmann F, Albrecht H, Padberg J, Grünewald T, Behnsch M, Grobusch M, Vallée M, Wünsche T, Ruf B, Suttorp N.
    J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
    [Abstract] [Full Text] [Related]

  • 7. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E.
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [Abstract] [Full Text] [Related]

  • 8. Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS.
    Monforte AD, Mainini F, Bini T, Moscatelli GC, Antinori S, Formenti T, Testa L, Mena M, Moroni M.
    J Chemother; 1995 Nov; 7 Suppl 4():184-6. PubMed ID: 8904150
    [No Abstract] [Full Text] [Related]

  • 9. Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.
    Miro JM, Lopez JC, Podzamczer D, Peña JM, Alberdi JC, Martínez E, Domingo P, Cosin J, Claramonte X, Arribas JR, Santín M, Ribera E, GESIDA 04/98 Study Group.
    Clin Infect Dis; 2006 Jul 01; 43(1):79-89. PubMed ID: 16758422
    [Abstract] [Full Text] [Related]

  • 10. Oral trimethoprim-sulfamethoxazole in the treatment of cerebral toxoplasmosis in AIDS patients--a prospective study.
    Francis P, Patel VB, Bill PL, Bhigjee AI.
    S Afr Med J; 2004 Jan 01; 94(1):51-3. PubMed ID: 14971234
    [Abstract] [Full Text] [Related]

  • 11. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi.
    Zachariah R, Spielmann MP, Harries AD, Gomani P, Bakali E.
    Int J Tuberc Lung Dis; 2002 Dec 01; 6(12):1046-50. PubMed ID: 12546111
    [Abstract] [Full Text] [Related]

  • 12. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
    Chaddha DS, Kalra SP, Singh AP, Gupta RM, Sanchetee PC.
    J Assoc Physicians India; 1999 Jul 01; 47(7):680-4. PubMed ID: 10778586
    [Abstract] [Full Text] [Related]

  • 13. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J, Munsiff SS, Driver CR, Sackoff J.
    Clin Infect Dis; 2005 Jul 01; 41(1):83-91. PubMed ID: 15937767
    [Abstract] [Full Text] [Related]

  • 14. Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responses.
    Hoffmann C, Ernst M, Meyer P, Wolf E, Rosenkranz T, Plettenberg A, Stoehr A, Horst HA, Marienfeld K, Lange C.
    Clin Microbiol Infect; 2007 May 01; 13(5):510-5. PubMed ID: 17298486
    [Abstract] [Full Text] [Related]

  • 15. Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapy.
    Guex AC, Radziwill AJ, Bucher HC.
    Clin Infect Dis; 2000 Mar 01; 30(3):602-3. PubMed ID: 10722454
    [No Abstract] [Full Text] [Related]

  • 16. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].
    Bossi P, Caumes E, Astagneau P, Li TS, Paris L, Mengual X, Katlama C, Bricaire F.
    Rev Med Interne; 1998 May 01; 19(5):313-7. PubMed ID: 9775164
    [Abstract] [Full Text] [Related]

  • 17. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?
    Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, Otieno K, Williamson J, Shi YP, Feikin DR, Marston B, Brooks JT, Poe A, Zhou Z, Ochieng B, Mintz E, Slutsker L.
    Am J Trop Med Hyg; 2008 Sep 01; 79(3):320-30. PubMed ID: 18784222
    [Abstract] [Full Text] [Related]

  • 18. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.
    Carr A, Tindall B, Brew BJ, Marriott DJ, Harkness JL, Penny R, Cooper DA.
    Ann Intern Med; 1992 Jul 15; 117(2):106-11. PubMed ID: 1351371
    [Abstract] [Full Text] [Related]

  • 19. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus.
    Richards FO, Kovacs JA, Luft BJ.
    Clin Infect Dis; 1995 Aug 15; 21 Suppl 1():S49-56. PubMed ID: 8547512
    [Abstract] [Full Text] [Related]

  • 20. Toxoplasmosis in HIV/AIDS patients: a current situation.
    Nissapatorn V, Lee C, Quek KF, Leong CL, Mahmud R, Abdullah KA.
    Jpn J Infect Dis; 2004 Aug 15; 57(4):160-5. PubMed ID: 15329448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.